<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000658785"><TermName>mocetinostat</TermName><TermPronunciation>(MOH-seh-TIH-noh-stat)</TermPronunciation><TermDefinition><DefinitionText>A substance being studied in the treatment of several types of cancer. It blocks enzymes needed for cell division and may kill cancer cells. It is a type of histone deacetylase (HDAC) inhibitor. Also called MGCD0103.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000726127" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;mocetinostat&quot;" language="en" id="_3"/><MediaLink ref="CDR0000726126" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;mocetinostat&quot;" language="es" id="_4"/><SpanishTermName>mocetinostat</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia en estudio para el tratamiento de varios tipos de cáncer. Bloquea enzimas que las células necesitan para multiplicarse y podría destruir células cancerosas. Es un tipo de inhibidor de la histona deacetilasa (HDAC). También se llama MGCD0103.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2009-11-03</DateFirstPublished></GlossaryTerm>
